Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Binimetinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 59,178Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer's Braftovi+Mektovi Demonstrates Prolonged Survival
    Pfizer's Braftovi+Mektovi Demonstrates Prolonged Survival

    22 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/pfizers-braftovimektovi-shows-sustained-long-term-survival-in-patients-with-advanced-lung-cancer-18042

    INDPHARMAPOST
    22 Oct 2025
    Share Share
    Pfizer's Braftovi + Mektovi Sustain Long-Term Survival in Cancer
    Pfizer's Braftovi + Mektovi Sustain Long-Term Survival in Cancer

    19 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-19/pfizer-s-braftovi-plus-mektovi-shows-sustained-long-term-survival-in-patients-with-advanced-lung-canc

    PHARMIWEB
    19 Oct 2025
    Share Share
    FDA Confirms Para IV Patent Litigation for Mektovi
    FDA Confirms Para IV Patent Litigation for Mektovi

    27 Aug 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-mektovi-54782.pdf

    FDA
    27 Aug 2025
    Share Share
    Pfizer's BRAFTOVI + MEKTOVI Shows Long-Term Response In NSCLC
    Pfizer's BRAFTOVI + MEKTOVI Shows Long-Term Response In NSCLC

    14 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240913128678/en

    BUSINESSWIRE
    14 Sep 2024
    Share Share
    EMA validates Pierre Fabre's MAA for BRAFTOVI
    EMA validates Pierre Fabre's MAA for BRAFTOVI

    02 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-medicines-agency-validates-pierre-fabre-laboratories-marketing-authorisation-application-for-combination-braftovi-encorafenib-and-mektovi-binimetinib-for-patients-with-brafv600-mutant-advanced-non-small-cell-lung-c-301975614.html

    PR NEWSWIRE
    02 Nov 2023
    Share Share
    US clears Pfizer's Braftovi, Mektovi combo for use in lung cancer
    US clears Pfizer's Braftovi, Mektovi combo for use in lung cancer

    13 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231011089993/en

    BUSINESSWIRE
    13 Oct 2023
    Share Share